Introduction
The rising engagement of magnetic particles in biomedical applications is strongly correlated to their key properties including physical structures, surface chemistry, and magnetic material parameter. [1] For magnetic separation, through tuning the surface chemical property of magnetic particles, various biological targets ranging from nano-to microscale can be selectively captured for therapeutic and diagnostic studies. In addition, the magnetic property of particles is crucial for the throughput and yield of separation in real applications. Particularly, the functionalized magnetic particles can be designed to specifically bind biomolecules for either immunoisolation of living cells [1e,2] or molecular profiling and detection. [1a,3] Meanwhile, laser desorption/ionization mass spectrometry (LDI-MS) has become a fundamental tool for molecular analysis by molecule weights (MW) allowing facile sample preparation, fast analytical experiments, and accurate structural identification. [4] In LDI-MS, magnetic particles can not only serve as chemo-specific materials for enrichment of target proteome/peptidome during sample pretreatment, [1a,3a-c] but also facilitate the LDI process for detection without the use of common organic matrix. [1a,4a,5] It is noted that most current efforts in magnetic particles based LDI-MS are focused on detection of bio-macromolecules like proteins and peptides; the application of magnetic particles dealing with small metabolites (M w < 500 Da) is yet to be explored for current metabolic analysis in cell research.
Cell metabolism is a dynamic process, which is crucial to reveal the intrinsic and extrinsic features of cells and investigate the cellular behavior in pathological and physiological phenomena. [6] However, characterizing cell metabolism is still challenging due to the low detection sensitivity, high sample complexity, and tedious preparation procedures, particularly for rare cells analysis in clinical study. [6a,7] In a case of circulating tumor cells (CTCs), blood-borne rare cells shed from the primary tumors, current full range of CTCs molecular characterization includes proteomic (e.g., immunofluorescence) and genetic strategies (such as fluorescence in situ hybridization and quantitative reverse transcription-polymerase chain reaction, qRT-PCR) to detect proteins and nucleic acids, respectively. [2a,b,8] Despite that, metabolism study of CTCs is largely hindered without a designer platform combining appropriate multiple analytical techniques, but can contribute to a new understanding of cancer metastasis and therapy resistance and to advances in precision medicine. [9] Therefore, invention of a new method is of great significance to address the challenges in the characterization of rare cells metabolism and will play a paramount role for the progress of tumor research.
Multifunctional Magnetic Particles for Combined Circulating Tumor Cells Isolation and Cellular Metabolism Detection
It should be noted that CTCs exist in extremely low abundance with one CTC in every one billion blood cells in the peripheral blood of patients. [10] Besides, their low recovery in downstream detection also poses a serious obstacle for CTCs isolation and analytical systems. [2c,11] In recent years, many approaches have been developed to selectively enrich CTCs according to their physical and chemical properties. [2b,10,12] To date, immunoassays are most commonly adapted to provide desirable capture specificity and efficiency by utilizing epithelial cell adhesion molecule (EpCAM) and its antibody. [2c,10a,13] For one example, satisfying the needs for high throughput, standardization, and easy operation, immunomagnetic particles based CellSearch platform serves as the only system approved by Food and Drug Administration in US for clinical CTCs analysis. [14] Nevertheless, immunomagnetic particles require rational design with multiple functions to facilitate the novel metabolic downstream analysis and maximize the therapeutic and diagnostic value of CTCs in clinics. [7] Previously we have reported particle assisted laser desorption/ionization mass spectrometry (PALDI-MS) for small metabolites analysis from biological samples [4a,15] and immunomagnetic assays for efficient CTCs isolation in blood. [2a,b,16] Herein, we demonstrated the combination of rare cell isolation and PALDI-MS to detect the metabolism of captured CTCs for metabolic study based on functional ferric oxide magnetic particles (Figure 1) . The magnetic particles were surface modified by anti-EpCAM for selective enrichment of CTCs, and more importantly, these particles served as ideal matrix for LDI-MS due to their nanoscaled size, stable structure, hydrophilic surface, and strong UV-light absorption. Consequently, sensitive PALDI-MS analysis can be achieved toward various small metabolites from complex biomixture due to the unique selective LDI process. Further isotope assisted quantification was coupled to investigate small molecules metabolism of ≈50 CTCs. This work starts a facile designer technology for downstream metabolic analysis of CTCs and provides new insights toward characteristics of rare cells in diverse dynamic biological process.
Results and Discussion

Preparation and Characterization of Functional Magnetic Particles
The functional ferric oxide particles were prepared by surface conjugation with anti-EpCAM, where the biotinylated antiEpCAM was linked to streptavidin-coated magnetic particles through biotin-streptavidin interaction as reported. [16a] As shown in Figure 2a , transmission election microscopy (TEM) demonstrated that the particles had a diameter of ≈200 nm (as previously selected) [2b] and were composed of ultrasmall magnetic nanocrystals (size of 3-6 nm). A coated layer can be observed with thickness ≈6-10 nm compared to the untreated particles ( Figure S1a Supporting Information) and TEM and suggesting their fine dispersity in solution for both cell capture and LDI matrix use.
Besides, the magnetic hysteresis loop of anti-EpCAM coated particles indicated their saturation magnetization value of 18.76 emu g −1 without remanence (lower than that of the initial particles in Figure S2a , Supporting Information, owing to surface conjugation [17] ), when cycling the field between −20 and 20 kOe. These particles can be quickly separated by a commercial permanent magnet in 40 s (inset of Figure 2c ) due to the fast response of magnetic nanoparticles. It should be mentioned that the ferric oxide particles exhibited strong absorption ≈280-1100 nm before and after the modification process ( Figure 2d and Figure S2b , Supporting Information), which would be critical for LDI-MS detection. [4a,5a,15a] The desirable size, stable structure, fine solution dispersity, superparamagnetic property, and UV-light absorption of the particles are essential for facile rare cell separation and a designed integration with LDI-MS detection.
Capture and Identification of CTCs by Immunomagnetic Assays
In the following CTCs capture experiments using MCF-7 cells (from human breast cancer, EpCAM positive) as targets, the pristine cells were shriveled to a size of ≈8 μm due to the drying process under SEM observations (Figure 3b ). For comparison, cell surface was densely decorated by particles ( Figure 3c and the zoomed image of particles on cell surface in Figure 3d ) after the immuomagnetic separation. For identification and screening experiments, fluorescence staining was performed to discriminate CTCs from nonspecific cells (e.g., white blood cells) as previously reported. [2a,16a] For a typical captured CTC, the bright field image illustrated a near-spherical shape of the cells with particles labeled cell surface on the edge area in accordance with SEM (Figure 4a Based on the above fluorescent analysis of each individual cell as captured, efficiency of the immunomagnetic assay can be determined by spiked experiments (see Section 4 for details). Over 99% and 85% of CTCs can be simply isolated from phosphate buffered saline (PBS) buffer and whole blood, respectively (Figure 4e) , by the use of functional magnetic particles for separation without any other devices except for a magnet. For selectivity test in Figure 4f , over 99% of MCF-7 cells (EpCAM positive) can be enriched through the immunomagnetic assay, whereas the nonspecific ratio was merely less than 3% in the case of Hela cells (EpCAM negative), evidencing the highly specific binding nature of the EpCAM modified particles. Moreover, the capture efficiencies for lower cell concentrations were investigated by spiking experiments in PBS and whole blood. Given the concentration ranging from 12 to 60 cells mL −1 over ≈90% and ≈82% of cells were captured in PBS buffer ( Figure 3g ) and whole blood (Figure 3h ), respectively. With the concentration lowered to 6 cells mL −1 , the capture rate still reached 72% in PBS and 66% in whole blood, suggesting that the functional particles can be effectively applied to capture cancer cells in real case. All these results demonstrated that our method can capture tumor cells with high sensitivity and has comparable results with current reports using magnetic particles or other techniques for rare cells separation. [2d,8b,18] Hence, successful launching of the immunomagnetic assays and identification of CTCs had been validated in different concentrated cells systems promising the next steps of cellular metabolism analysis.
Detection of Small Metabolites Using the Magnetic Particles
These functional magnetic particles can not only be used as a specific labeling reagent for CTCs isolation, but also contribute to efficient LDI-MS detection of small metabolites. As displayed in Figure 5a -i, no molecular peaks can be viewed from a standard metabolites mixture (containing glucose, sucrose, phenylalanine, and glutamic acid) without any matrix suggesting the very low LDI efficiency. When conventional α-cyano-4-hydroxycinnamic acid (CHCA) was applied (Figure 5b-i) , strong interference signals appeared in the low mass range (<500 Da) and only weak peaks of metabolites can be observed due to the fragmentation and interference of organic matrix. [4a,5a] In parallel, group of specific peaks from small molecules can be obtained in Figure 5c- Figure S4 , Supporting Information, for the LDI-MS results of each standard molecule using the particles and Table S1 (Supporting Information) for the accurate masses with detection-of-limits measured). These results revealed the high performance of these particles in small metabolites detection due to their desirable structural parameters as characterized in Figure 2 , which is comparable to the current reports and materials in LDI-MS. [4a,5a,b,15a,19] Further, we demonstrated the selective LDI of small metabolites [15a] by the particles from complex biomixtures. In control experiments, no small molecules can be detected in peptides mixtures (Figure 5a -ii and Figure S5a ,d, Supporting Information) and proteins mixtures (Figure 5a -iii and Figure S6a ,d, Supporting Information) without any matrix in the low mass range due to low LDI efficacy. In contrast, the peptides and proteins can be well recognized by the use of CHCA matrix as shown in Figure 5b -ii (also Figure S5b ,e, Supporting Information) and Figure 5b -iii (also Figure S6b ,e, Supporting Information), respectively. When the magnetic particles were employed, the peptides/proteins could not be detected (Figure 5c -ii,iii and Figures S5c,f and S6c,f, Supporting Information), and the small metabolites can be well identified in mixtures (the insets of Figure 5c -ii,iii and Figures S5c,f and S6c,f, Supporting Information). These results validated that the magnetic particles were able to selectively enhance the LDI efficiency of small metabolites in diverse peptides/proteins biomixtures during MS analysis superior to traditional organic matrix, which is advantageous for their applications in metabolic detection of biosamples with high sample complexity in nature.
Isotopic Assisted LDI-MS Analysis of CTCs Metabolism
In the final stage, we implemented combined CTCs isolation and cellular metabolism detection using the immunomagnetic particles. No signals from metabolites can be observed by direct LDI-MS of ≈50 pristine MCF-7 cells without matrices (Figure 6a) , whereas strong background signals can be found in the spectra and detection was failed using the traditional organic matrix ( Figure S7 Figure 6b ) due to the unique selective LDI process as demonstrated by our previous steps ( Figure 5 and Figures S5 and S6, Supporting Information) , showing the key role of magnetic particles for both immunomagnetic assay and LDI-MS. It should be noted that the peak intensity in LDI-MS cannot be directly used for quantification purpose due to the nonpredictable ionization behavior. [20] To investigate the metabolism velocity of the captured CTCs, the isotopic assisted technique was introduced (using isotopes of small molecules as the internal standard) in LDI-MS for quantification. [19b,c] Typical MS spectra for metabolites detection using isotopic standards have been listed in Figure 6c The as-measured intensity ratios revealed the content of metabolites and can be used to estimate the metabolism velocity of selected small metabolites. For cellular carbohydrates metabolism, Figure 7a revealed that glucose can be consumed over by ≈50 CTCs after 24 h with a/i ratio reduced from 0.604 to 0, while the metabolism velocity was much slower in the case of sucrose (a/i reduced from 0.707 to 0.503, Figure 7b ). In parallel, for cellular amino acids metabolism, the metabolism velocity can also be quite distinct for different molecules. The consumption of phenylalanine (a/i reduced from 0.751 to 0, Figure 7c ) was much faster than that of glutamic acid (a/i reduced from 0.554 to 0.371, Figure 7d) by the CTCs. It should be noted that a blank control without any cell and a control group with normal cells were conducted to validate the above observations. For standard solutions without cells, the a/i ratio after 24 h remained the same as 0 h and no consumption of metabolites can be found for the four metabolites ( Figures S8 and S9 , Supporting Information). When normal white blood cells were evaluated using the same procedures for MCF-7 cells, we still did not observe any consumption of metabolites for the four metabolites (with a/i ratio unchanged, Figures S10 and S11, Supporting Information) due to the fact that the functional magnetic particles cannot target normal cells (EpCAM negative) for detection of metabolites. Therefore, we demonstrated unique performance of these particles in monitoring the metabolism of CTCs, which may provide new insights into cancer metastasis associated CTCs in clinics. [21] We concluded that the functional magnetic particles bridged the immunomagnetic assay and LDI-MS for efficient CTCs capture and metabolism study, where the metabolism velocity of various molecules can be studied during the downstream analysis of CTCs.
Conclusion
In summary, characterizing metabolism of CTCs reveals the virtual cellular process and complements the proteomic and genomic studies of these rare cells. In this work, we for the first time combined CTCs isolation and cellular metabolism detection based on designed magnetic particles (Figure 1) . The key features of our method can be concluded as follows: (I) immunomagnetic particles with designed size, dispersity, magnetic response, and functional surface (Figure 2a-c) for efficient capture of CTCs from spiked samples at low cells concentrations ( Figures 3 and 4) ; (II) stable structure of the particles with strong UV laser absorption (Figure 2a,d ) for sensitive ( Figure S4 and Table S1 , Supporting Information) and selective LDI-MS analysis of metabolites from complicated biomixtures ( Figure 5 ; Figures S5 and S6, Supporting Information); (III) isotopic quantification to monitor selected small molecules (e.g., carbohydrates and amino acids) metabolism of ≈50 captured CTCs (Figures 6 and 7) . This work represents a key step forward for rare cell analysis to explore the biological features of CTCs and investigate their cellular responses in diverse pathological and physiological processes. 
Experimental Section
Preparation of Functional Magnetic Particles: Immunomagnetic particles were prepared by surface immobilization with anti-EpCAM. The initial magnetic particles (size of 200 nm) were synthesized by an in-solution approach and coated by polymers (Mix&Go from Anteo Diagnostic) to conjugate with streptavidin as reported. [22] Then the streptavidin modified magnetic particles were incubated with biotinylated anti-EpCAM (Abcam Inc., Cambridge, USA) for final functionalization. Briefly, 100 μL of streptavidin magnetic particles (10 mg mL −1 ) was mixed with 50 μL of biotinylated anti-EpCAM (0.2 mg mL −1 ) and gently shaken at room temperature for 1 h. The activated particles were collected by magnetic separator and washed two times with PBS to remove surplus antibodies. Then a blocking procedure was performed by adding 1 mL of blocking buffer (10% bovine serum albumin, BSA) to avoid potential nonspecific interactions during cell isolation. Finally, the blocked particles were washed two times with PBS containing 0.1% Tween 20 (PBST) and stored in storage buffer (PBS containing 0.5% BSA, 0.5% Tween 20 and 0.02% ProClin 300) at a concentration of 1 mg mL −1 at 4 °C before use.
Characterization Methods and Techniques: TEM images were recorded by a JEOL JEM-2100F TEM instrument. The samples were prepared by depositing 10 μL of particles suspension onto a copper TEM grid before observation. SEM analysis was performed on Hitachi S-4800 operating at 10 kV. The suspensions of particles/cells were deposited on silicon wafer and directly observed in the SEM device after drying at room temperature. Magnetic hysteresis loops were measured using a vibrating sample magnetometer (Quantum Design, Physical Property Measurement System). DLS measurements were conducted on a Malvern Zetasizer Nano ZS instrument by dispersing the magnetic particles in water. Room temperature optical absorption spectra of the materials were obtained on an AuCy UV1900 spectrophotometer.
Immunomagnetic Isolation of CTCs: Human breast cancer cell lines, MCF-7 cells (EpCAM positive), and cervical cancer cell lines, Hela cells (EpCAM negative), were used as rare cells models to determine the efficiency and specificity of immunomagnetic assay in our work. These cells were maintained as reported in modified media consisting of high-glucose dulbecco's modified eagle's medium (DMEM) supplemented with fetal bovine serum, penicillin, and streptomycin. To harvest cells, 1 mL of trypsin (0.25%) was dropped into flask for 5 min digestion in the CO 2 incubator and the obtained cells were washed two times with PBS buffer. Counting of cells was performed using trypan blue and hemocytometer under the microscopy (Olympus CKX 41). Both PBS buffer and whole blood were utilized to resuspend the cells during the spiked experiments. All of the investigation protocols in this study were approved by the institutional ethics committee of the Shanghai Chest Hospital and School of Biomedical Engineering, Shanghai Jiao Tong University. Written informed consents were obtained since the project had . LDI-MS analysis of captured MCF-7 cells. MS spectra of a) ≈50 pristine MCF-7 cells without matrix and b) ≈50 captured MCF-7 cells in 100 ng μL −1 glucose. MS spectra of carbohydrates metabolites for glucose and internal standard (IS) isotope c) before (0 h) and d) after 24 h metabolic time; sucrose and IS isotope e) before (0 h) and f) after 24 h metabolic time. MS spectra of amino acids for phenylalanine and IS isotope g) before (0 h) and h) after 24 h metabolic time; glutamic acid and IS isotope i) before (0 h) and j) after 24 h metabolic time. The represented metabolites and the represented corresponding IS isotopes in (c-j).
www.afm-journal.de www.MaterialsViews.com started. For selective cell enrichment, 100 μL of as-prepared particles (1 mg mL −1 ) was added to the system (2 mL of PBS with 5% BSA or 2 mL of whole blood) containing ≈200 MCF-7/Hela cells spiked before.
For cell isolation at lower concentration, from 6 to 60 cells were spiked in 1 mL PBS or whole blood. After incubating the mixture by gently shaking at 37 °C for 1 h, magnetic particles labeled cells were collected by magnetic separator, washed two times and resuspended in 100 μL of PBS before cell counting. By using the fluorescence staining, the number of captured cells is N. Then the capture rate can be calculated through Equation (1) 
LDI-MS of Small Metabolites:
In LDI-MS, using organic matrix, CHCA solution (50/50/0.1, v/v/v, water/acetonitrile/trifluoroacetic acid) was prepared at a concentration of 10 mg mL −1 . 500 nL analytes solution was pipetted on the plate and dried at the room temperature. Then 500 nL of matrix solution was dropped on the plate and dried for LDI-MS analysis. For LDI-MS using magnetic particles, these particles were dispersed in water at a concentration of 1 mg mL −1 . Then 500 nL matrix slurry was prepared after dropping 500 nL of analytes solution on the plate and dried for LDI-MS analysis. Standard small molecules (>99.99% purity) were purchased from SinaPharm Chemical Regent (Beijing) and SigmaAldrich (USA). The peptides (from protein digests) and proteins mixtures were prepared using established methods. [20b,23] Mass spectra were acquired in the positive reflection mode on 5800 Proteomics Analyzer (Applied Biosystems) with the Nd:YAG laser at 355 nm, a repetition rate of 200 Hz, and an acceleration voltage of 20 kV. All spectra were used as recorded without any smoothing and the delay time was optimized to be 500 ns in the experiments. Only MS signals with signal-to-noise ratio over 10 were used for identification of molecules based on accurate mass measurement (±10 mDa). [15a,24] No smooth spectra were used and all spectra were directly used for analysis.
Downstream Analysis of CTCs:
In cell counting and identification, the fluorescence staining method was employed by the use of DAPI (Vector Laboratories Inc., UK), anti-CK pan FITC (Sigma-Aldrich Co., USA), and cy3 labeled anti-CD45 (Biorbyt, USA). Briefly, captured cells were dispersed in PBS and dropped on a glass slide for drying at 37 °C for 2 h. Subsequently, excessive ice-cold acetone was introduced to the glass slides to fix the cells. Then the cells were stained with DAPI, anti-CK pan FITC, and cy3 labeled anti-CD45. Additionally, the fluorescence images of white blood cells were examined as control. The cells that had roundto-oval morphology and were positive for DAPI (specific for DNA) and CK (a marker for epithelial cells) and negative for CD45 (expressed in leukocytes) were identified as MCF-7 cells, while the cells that were positive for DAPI and CD45 and negative for CK were identified as white blood cells.
In the detection of cellular metabolism, the cells captured by magnetic particles were dispersed at a concentration of 50 cells μL −1 in buffer solution containing small metabolites including sugar molecules (glucose, sucrose) and amino acids (glutamic acid, phenylalanine). Typically, 1 μL of mixture containing ≈50 cells was deposited on the plate and dried at the room temperature for direct LDI-MS analysis on 5800 Proteomics Analyzer similar to the previous step. Then the mixture was analyzed by LDI-MS using the magnetic particles as matrix for cellular metabolism analysis and isotopic quantification was employed based on the peak intensity ratio of analytes and isotopic internal standards. [19b,c] Fixed amounts of isotopes were added and the peak intensity ratio was measured before and after 24 h incubation. Five independent experiments were conducted in parallel to measure the signal ratios and the isotopic internal standards of small metabolites (labeled with 13 C or D) were purchased from Cambridge Isotope Laboratories, USA. For control groups, both standard solutions without any cell and normal white blood cells were employed in experiments. All the four metabolites including glucose, sucrose, glutamic acid, and phenylalanine were tested and the same experimental procedures as for the CTCs were conducted for the cells isolation and metabolism detection. 
